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Abstract
Background: Although screening for tobacco use is increasing with electronic health records and standard
protocols, other tobacco-control activities, such as referral of patients to cessation resources, is quite low. In the
QUIT-PRIMO study, an online referral portal will allow providers to enter smokers’ email addresses into the system.
Upon returning home, the smokers will receive automated emails providing education about tobacco cessation
and encouragement to use the patient smoking cessation website (with interactive tools, educational resources,
motivational email messages, secure messaging with a tobacco treatment specialist, and online support group).
Methods: The informatics system will be evaluated in a comparative effectiveness trial of 160 community-based
primary care practices, cluster-randomized at the practice level. In the QUIT-PRIMO intervention, patients will be
provided a paper information-prescription referral and then “e-referred” to the system. In the comparison group,
patients will receive only the paper-based information-prescription referral with the website address. Once patients
go to the website, they are subsequently randomized within practices to either a standard patient smoking
cessation website or an augmented version with access to a tobacco treatment specialist online, motivational
emails, and an online support group. We will compare intervention and control practice participation (referral rates)
and patient participation (proportion referred who go to the website). We will then compare the effectiveness of
the standard and augmented patient websites.
Discussion: Our goal is to evaluate an integrated informatics solution to increase access to web-delivered smoking
cessation support. We will analyze the impact of this integrated system in terms of process (provider e-referral and
patient login) and patient outcomes (six-month smoking cessation).
Trial Registration: Web-delivered Provider Intervention for Tobacco Control (QUIT-PRIMO) - a randomized
controlled trial: NCT00797628.
Background
Tobacco use is the number one behavioral health pro-
blem and number one preventable cause of death [1-5].
Interventions to reduce smoking have most frequently
targeted patients. Patient self-management interventions
for smoking cessation include mass dissemination of
tobacco cessation self-help materials, computer-tailored
printouts, interactive voice response systems, and more
recently, “quitlines” and smoking cessation websites
[3,6-13]. Unfortunately, self-management interventions
for smoking cessation have been underutilized. Studies of
quitlines note that as little as 3.5% of adult smokers call
per year [14]. Because the majority of smokers (70%) see
a healthcare provider at least once per year [15], physi-
cian referrals could greatly increase use of publicly avail-
able self-management interventions for smoking.
Quality improvement and implementation interven-
tions have tried to change processes of care or provider
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Brief clinical interventions, based on tobacco use screen-
ing and brief, structured cessation advice from a provi-
der, have been documented to improve patient cessation
rates [15-18]. The current US Department of Health
and Human Services clinical practice guideline entitled
“Treating Tobacco Use and Dependence” provides a
summary of evidence-based recommendations [5]. The
current guideline includes a framework for structured,
brief clinical interventions using the “5 As” of
counseling:
1. Ask: Identify and document tobacco use status for
every patient at every visit.
2. Advise: In a clear, strong, and personalized manner,
urge every tobacco user to quit.
3. Assess: Is the tobacco user willing to make a quit
attempt at this time?
4. Assist: Refer to resources and provide pharma-
cotherapy and counseling.
5. Arrange: Schedule follow-up contact, preferably
within the first week after the quit date.
The first two As (Ask and Advise) have increased
through system-based interventions (i.e., smoking status
as a vital sign) [19,20] and audit and feedback of smok-
ing counseling performance [21,22]. However, imple-
mentation of Assist and Arrange has been lower
[21,23,24]. One important component of assisting
patients mentioned in the guideline is to refer patients
to community resources, such as quitlines [15]. As qui-
tlines and websites have proliferated, “Refer,” as part of
the Assist agenda, has been increasingly emphasized
[25]. In practice, rates of referral to cessation resources
have been measured to be as high as 28% at the VA
[26] and 37% in managed care [27] and as low as 10%
in community-based practices [28]. Providers do refer
some patients to quitlines. In one study, 20% of quitline
users were referred by providers [29]. Barriers to Refer
include provider’s lack of (a) time due to competing
demands, (b) awareness of referral resources, (c)
prompts, (d) materials to facilitate referrals, and (e) feed-
back on referral’s success [30]. Both patient and provi-
der barriers to using resources for smoking cessation
could potentially be addressed with an integrated
system.
In this report, we describe the protocol for the QUIT-
PRIMO-quality improvement in tobacco-provider refer-
rals and Internet-delivered microsystem optimization-
provider-to-patient informatics system. The informatics
system will allow providers at the point of care to use a
simple web portal to “e-refer” patients to a smoking ces-
sation website. Providers simply type the smokers’ email
into the ReferaSmoker. Patients will then receive moti-
vational emails encouraging them to join the patient
intervention website (with interactive tools, educational
resources, motivational email messages, secure messa-
ging with tobacco treatment specialists and an online
support group). Providers will subsequently get reports
of patient activity on the smoking cessation website.
Our overall goal is to advance science related to the
use and impact of the Internet in health services delivery
of tobacco control. Because the informatics system is
designed to engage all providers in a primary care clinic,
including physicians and nurses, we will evaluate the
system in a cluster-randomized trial. We will randomize
160 primary care clinical microsystems to the interven-
tion or comparison group. For both the intervention
and comparison groups, we will adapt protocols used in
prior successful Internet-delivered provider interventions
to recruit practices and implement the system in prac-
tices [31,32]. Because our trial targets both practices and
patients, patients within practices undergo a second
level of randomization, as described below. We will use
the discussion of our cluster-randomized trial to detail
our approach to inherent measurement challenges in
this randomized trial of a mixed provider-patient infor-
matics intervention.
Methods
Study design
We will recruit 160 primary care physician practices to
our trial. As further detailed below, our primary inter-
vention target is the clinical practices. Patients nested
within these practices will be cluster-randomized to
receive either a simple paper referral or the full inter-
vention-a paper referral plus an “e-referral” (smoker’s
email will be entered into a referral system and the smo-
ker will receive encouraging emails to participate). In
addition to our primary cluster-randomized trial,
patients who participate in the website will be further
randomized (patient-level, within-practice randomiza-
tion) to receive either a standard or augmented patient
website. Thus, our design is a randomized trial of a
patient smoking cessation intervention, nested within a
cluster-randomized practice intervention.
Participants
Our target is the primary care clinical microsystem
within family practice and general internal medicine
practices from across the United States. A clinical
microsystem is defined as the smallest functional health-
care unit. A clinical microsystem is not simply equiva-
lent to a group of doctors, but includes the clinical team
of nurses, the processes of care that are used, and the
panel of patients cared for by the providers. The Insti-
tute for Healthcare Improvement states that interven-
tions targeted to clinical microsystems are “ac r u c i a l
component in improving health care quality.” [33] Our
informatics intervention targets both the practice staff
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are described as participants.
Participating practices
Practices will be recruited using a database of registered
internal medicine and family/general practitioners.
Initial interest will be ascertained via mass mailing of an
interest survey. Once initial interest is expressed by
return of the brief interest survey, each practice will be
assessed for inclusion.
We are including community-based primary care
practices (general internal medicine and family practice).
Exclusion criteria include those practices that do not
have Internet access available to staff and practices that
do not see at least five or more smokers in one week. In
addition, we will selectively recruit practices that have
five or less providers. Based on our prior experience,
enrollment of practices in these studies is complex and
is somewhat easier if the number of providers in the
practice is lower. Thus, we will exclude practices that
have greater than five physicians. We will also exclude
practices with ongoing computer-based smoking cessa-
tion programs, and we will not recruit from practices
participating in ongoing studies or similar prior studies,
especially those focused on tobacco control.
Participating patients
Patients will be referred to an online smoking cessation
system (Decide2Quit.org). Patients referred will be adult
smokers in the intervention and comparison practices.
Decide2Quit.org is designed as a cessation induction
and support for quitting system, tailored to readiness to
quit. Thus, we are including those ready to quit, think-
ing about quitting, or not thinking about quitting.
Interventions
Our discussion of the interventions begins with a com-
parison of the practice-level intervention.
ReferaSmoker.org, the practice-level intervention
Intervention practices will be provided preprinted pads
of “information prescriptions” with their office informa-
tion, a space for the provider to sign, and the smoking
cessation website address (Decide2Quit.org). The infor-
mation prescriptions are perforated; half will be retained
by the practice (including the patient email to be used
for e-referral) and half will be provided to the patient
(see Additional File 1, Appendix 1). Practices will then
use this patient email collection to e-refer them through
ReferaSmoker.org. The core of the ReferaSmoker.org
provider portal is a secure sockets layer (SSL) encrypted
web form where providers can enter patients’ email
addresses into the system if they agree to be referred
(Figure 1). The form has been designed to be easily
completed by nursing or front office staff as the patient
is discharged from the visit. Online referrals through the
SSL form will be tracked by the server. The practice-
reports function will provide feedback reports to provi-
ders on their patients’ progress and their practice’s
referral rates. These feedback reports will act as a proxi-
mal outcome, where providers of all types can actually
observe the impact of their efforts. To maximize the use
of ReferaSmoker.org, we also provide supportive sub
modules designed to prompt providers to use the system
and maximize their smoking cessation activities (Figure 1,
ReferaSmoker #3).
ReferaSmoker.org implementation program
After practices are enrolled, we will then schedule and
conduct individualized telephone trainings with two
implementation coordinators (physicians, nurses, or
other staff) chosen at each practice. We chose two
implementation coordinators per practice because of
high rates of turnover of office staff in our prior experi-
ences. Two coordinators can provide each other backup
and further enhance use of ReferaSmoker.org. Using an
academic detailing approach, our study team will walk
the implementation coordinators through the ReferaS-
moker website, including initial registration, and practice
e-referring a test patient.
Using motivational interviewing, we will work with the
implementation coordinators to identify barriers and
strategize solutions to enhance participation. Implemen-
tation coordinators will set a goal for number of refer-
rals per week based on their practice volume.
Implementation coordinators will be trained on register-
ing other providers in the practice into the system.
Based on pilot testing and focus groups, we have iden-
tified specific incentives, including provision of continu-
ing education credits to participating providers and a
$1,000 per practice “implementation budget” for com-
pleting training and referring their first 20 smokers.
Proactive booster calls will be scheduled one month
after initial registration to assess progress, respond to
any questions, and continue to motivate participation.
The practice-level comparison
The practice-comparison referral process ends at the
information prescriptions. Comparison practices will be
enrolled in the same manner and will participate in the
implementation program training calls. Randomization
will occur on the calls once registration is complete, as
further described below. The ReferaSmoker.org portal
changes dynamically based on the randomization status
of the practice, and comparison practices will only
receive the supportive educational materials (Figure 1,
ReferaSmoker #3). Comparison practices do not have
access to the e-referral system, the practice feedback
dashboard, or the secure messaging system.
As noted, comparison practices are provided pre-
printed pads of information prescriptions, exactly like
those the intervention practice received, save one detail.
There is no space for the patient email because control
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tional File 2, Appendix 2). Smokers will be provided half
the information prescriptions, with the Decide2Quit.org
address, just as with the intervention practices. All other
components of the implementation program, motiva-
tional interviewing and goal-setting, incentives, and
booster calls are kept constant across the two arms.
Practices randomized to the comparison do receive a
more limited training, focusing on the paper informa-
tion prescriptions.
Decide2Quit.org, the patient-level intervention
Providers refer patients to Decide2Quit.org by paper
prescription in the comparison group or by paper plus
e-referral in the intervention group. Patients e-referred
to Decide2Quit.org will receive reminder emails (two
per week for four weeks) as cues to participation.
Patients who follow the referral and register with
Decide2Quit.org will complete an online consent form
and a baseline survey, including assessment of their
readiness to quit smoking. This baseline data will be
used to tailor the website to the individual.
Once registration is complete, smokers from both
intervention and control practices will be further rando-
mized. This within-practice randomization will allow
smokers to receive one of two versions of Decide2Quit.
org: a standard Decide2Quit.org or an augmented ver-
sion of Decide2Quit.org (Table 1).
The standard comparison Decide2Quit.org includes a
library of information about quitting smoking, including
educational content about talking to a doctor about
quitting smoking and detailed information on medica-
tions and behavioral treatments. The system also
includes content about seeking help from friends and
family, a chemicals-in-smoking matching game, and a
decisional-balance “what will I have to overcome” calcu-
lator with individualized feedback. Smokers can com-
plete a personalized “Quit Plan” that they can print and
share with their provider.
The augmented Decide2Quit.org intervention includes
all the components of the standard intervention plus (a)
pushed motivational emails tailored to readiness to quit
and designed to motivate cessation and market the
Decide2Quit.org intervention; (b) secure asynchronous
messaging with a personal advisor, a trained tobacco
treatment specialist; and (c) an online support group
community (Table 1).
Thus, our study is a cluster-randomized trial, with
patients clustered at the practice level, and a subsequent,
Figure 1 Major components* of QUIT-PRIMO provider-patient informatics intervention. * All components are supported by repeated,
targeted email reminders designed to prompt participation and cue increased smoking cessation. Emails will invite enrolled smokers, provide
motivational and educational messages to enrolled smokers, notify providers of new web reports, and alert providers to new messages from
patients. A proactive Help Desk will also be available as part of the intervention.
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This is further detailed under Randomization below.
Objectives
As conceptualized for one patient in an example prac-
tice depicted in Figure 3, the intervention is designed
to have a sequence of effects on the process of care
within each clinical microsystem. The system has the
potential to impact provider behavior (nurses and phy-
sicians), processes of care, and patient behavior. Thus,
we have designed our main evaluation to assess several
key areas of influence, which we have abbreviated as
Table 1 Major components of Decide2Quit.org
Component Description
MyMail
a Receive messages from a tobacco treatment specialist
Our Advice
a Receive encouraging email messages from experts; messages tailored to stage of change
Your Online Community
a View messages and dialogue from smokers and ex-smokers through a resource website
My Health Risks
b Learn about specific health risks, including physical symptoms and harmful chemicals
Thinking About Quitting
b Helpful ideas and motivational recommendations (e.g., interactive calculators assessing triggers, decisional balance)
Family Tools
b How to get help from your family, deal with nagging, learn what kids think about smoking
Healthcare Provider Tools
b How to include your healthcare provider in your quit smoking plan
The Library
b Download articles and helpful tools about smoking cessation and smoking treatments
Web Resources
b Valuable additional websites for smokers
aThese components are available only to the augmented Decide2Quit.org intervention;
bStandard components available to all smokers registered to Decide2Quit.
org, both those randomized to standard version and those randomized to augmented version.
Figure 2 Enrollment and randomization strategy.
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provider and patient intervention, we have proposed
the following three hypotheses:
Hypothesis 1 (Refer): More patients will be Referred
to the Decide2Quit self-management resource web-
site in the QUIT-PRIMO e-referral practices com-
pared with information prescription practices.
Hypothesis 2 (Go): The proportion of referred
patients who Go to the patient self-management
website due to the QUIT-PRIMO practice proactive
e-referrals will be greater compared with the paper
information-prescription practices.
Hypothesis 3 (Quit): The proportion of referred smo-
kers who Quit at six months will be greater among
those in the augmented Decide2Quit.org intervention
compared with the standard intervention.
Outcomes
For our three hypotheses, we have three primary out-
come variables (i.e. ,R e f e r ,G o ,Q u i t ) .F o rt h ep r i m a r y
analysis for hypothesis 1, the outcome will be the number
of smokers referred from each group transformed into an
average count per month by dividing the total by the
length of time in months from the practice’s first referral.
As discussed above, in both arms, practices will use
paper information prescriptions. The leave-behind part
of the information prescription (see Appendix 1) will
allow a consistent measure ofr e f e r r a l s .I nt h eQ U I T -
PRIMO intervention, the server will track the number of
electronic referrals, allowing us to compare rates of refer-
ral based on paper and server in the intervention arm.
For hypothesis 2, our outcome will be the proportion
of those referred who go to the website. Our interest in
hypothesis 2, expressed as a proportion, will be the pro-
portion of patients referred who log on, or “Go,” to the
website (% who go = number who visit/number
referred). The number of smokers who visit will be
recorded by the Decide2Quit system, linking each visitor
to their primary care provider at initial registration. The
number referred is continuously registered directly by
the leave-behind referral receipts of the information
prescriptions.
For hypothesis 3, we will define the outcome in two
ways. In both approaches, the numerator will be the
Figure 3 How the integrated QUIT-PRIMO is conceptualized to improve processes of care (5 As) and increase smoking cessation: use
of the clinical microsystem intervention over time by one example practice and one patient. A1: Ask–ReferaSmoker sends email prompts
to providers reminding them of the importance of smoking cessation; provider downloads printable chart stickers, etc., to increase systematic
screening by nurses. A2: Advise–ReferaSmoker materials provide additional knowledge to providers on strong advice; provider advises patient.
A3: Assess–Provider explains content of Decide2Quit and assesses willingness of patient to use system and to quit. A4: Assist–Patient agrees to
be recruited and nurse enters patient email into ReferaSmoker online portal and patient is enrolled into the system. Decide2Quit sends email
reminders to the patient. Patient uses system and talks to family because of the motivational messages. A4: Assist–Patient engages in the
online support group, shares his quitting experiences and finds others with similar experiences, posts a question online, and interacts with other
smokers trying to quit. A4: Assist–Patient selects a tobacco treatment specialist (TTS) and posts a question to her using the MyMail feature of
the system. The TTS responds with helpful suggestions, and the patient returns to the system to read her responses. A4: Assist–Patient
continuously receives tailored “advice” emails from the system. Emails are from experts and peers. A5: Arrange–Nurse (and/or physician) reviews
reports of patient use and follows up. Nurse sends a template-driven email message encouraging use of the system and offering treatment. A4:
(more) Assist–Patient returns to Decide2Quit repeatedly, is increasingly motivated, requests treatments ® quits.
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follow-up calls. In our primary intent-to-treat analysis,
the denominator will be all smokers who are referred
(the same denominator used in hypothesis 2), estimating
a population effect. This represents a conservative
assessment since we assume that many patients will not
go, and for the purposes of analyses, we will assume
that these patients will not have quit. As a secondary
analysis, we will assign the denominator as the number
of patients who go to the website. For this secondary
outcome, consistent with current guidelines for smoking
cessation trials, we will assume that patients who are
lost to follow-up, including those who go and do not
agree to follow-up, are smokers [34].
Sample size
We calculated sample size for each of our three hypoth-
eses. Power was primarily driven by hypothesis 3 (six-
month cessation). We first estimated the number of
smokers per practice that will participate in the website
over time. The average patient panel of a primary care
provider is approximately 2,300, although not all are
seen in a given year. We estimated 1,500 visits per year.
Based on tobacco use prevalence, approximately 22% of
t h ep a t i e n t sw i l lb es m o k e r s .T ob ec o n s e r v a t i v e ,w e
assume that we will have only two providers per practice
actively participating in the intervention. Using these
numbers, we have estimated the number that will parti-
cipate per practice yearly (Table 2). We expect 158
referrals from each intervention practice and 79 from
each control practice. Based on these samples, and
assuming a cessation rate of 10% among patients rando-
mized to the standard Decide2Quit.org, we have 80%
power to detect a 5% difference in cessation, comparing
the standard and augmented Decide2Quit.org.
Randomization
Sequence generation and implementation
Practices will be recruited utilizing a mass mailing. An
initial interest letter will be sent describing the study
and that participation will provide access to tools aimed
at enhancing referral of patients to a customized smok-
ing cessation intervention website. Practice eligibility
will be determined based on the interest survey, and
practices will subsequently be asked to complete a prac-
tice consent form and baseline practice survey. With
survey and consent returned, our study staff will contact
practices and identify and train two implementation
coordinators, nurses, or other practice staff who will
participate in the referral process. Our staff will talk the
implementation coordinators through registration and
the referral process. During training, the first implemen-
tation coordinator will complete an online consent and
survey, followed by randomization.
We developed an online randomization program,
based on a block-randomization strategy (a randomiza-
tion table with blocks of 10) linked to registration. Our
statistician, JR, developed the randomization table and
only JR and RSS (who developed the randomization sys-
tem) have access to the table. When the first user from
a practice is randomized, the system will look up the
next allocation in the randomization table and the user-
provider then has access to the intervention or compari-
son version of ReferaSmoker.org. All subsequent provi-
ders from the sample practice will then be randomized
to the same arm.
Patients will also be randomized to the standard Deci-
de2Quit.org or augmented Decide2Quit.org using the
online randomization program but using a separate ran-
domization table, also generated by JR.
Blinding (masking)
Because each practice is informed, they will be provided
tools aimed at enhancing referral, and since specifics of
either arm are not described at any time, the practice is
blind to group assignment. During the training process
up to the point of randomization, the study coordinator
is blind to which arm the practice will be assigned; how-
ever, they are unblinded once randomization occurs in
order to provide direction for the appropriate referral
process. Each study coordinator is trained to minimize
any bias in communication with the implementation
coordinators based on which arm they are assigned.
Practices remain blind. In turn, all patients are blind to
website characteristics and which randomized group
they will be assigned to. Patients remain blind until
completion of the study. At completion of the study, all
practices and patients are unblinded and given the
opportunity to utilize all features of both websites.
Analysis
The mean number of referrals per month will be com-
pared by study group using a two-sided t-test, employ-
ing Satterthwaite’s approximation if the variances are
substantially different. We will also examine the
Table 2 Flow of 3,000
a patients through the
intervention–Refer ® Go ® Quit
Intervention Control
Start with 3,000 patient
visits
Percent Resulting
N
Percent Resulting
N
Smokers 22% 660 22% 660
Smokers REFERred 24% 158 12% 79
Smokers referred who GO 40% 63 20% 16
Smokers that go who
QUIT
15% 10 10% 2
a3,000 patient visits (1,500 per year over two years).
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and will use the two-sided Wilcoxon test if they appear
non-Gaussian. We will assess the adequacy of randomi-
zation on characteristics of the practice that might influ-
ence referral rates. We will have data from an
administrative database (size of practice, number of pro-
viders and staff) and provider reports of proportion of
smokers in the practice. We will also conduct adjusted
(using Poisson or negative binomial models based on
distribution) analyses accounting for these factors.
For hypothesis 2, whether or not a patient goes will be
considered a dichotomous outcome in a patient-level
analysis. The main patient-level analysis will use a gen-
eralized linear model with a logit link to evaluate
whether a referred smoker goes to the patient website.
As this hypothesis represents a cluster-randomized trial,
because each website links patients back to their prac-
tice, we will use generalized estimating equation (GEE)
methods to account for clustering within practices.
For hypothesis 3, patients will be randomized within
practices to standard Decide2Quit and augmented Deci-
de2Quit. Because we are comparing rates in all instances
between the standard Decide2Quit system and the aug-
mented Decide2Quit, we will use a two-group chi-
square test of equal proportions to test the statistical
difference between the quit rates. We will next use a
generalized linear model with a logit link to model
tobacco cessation by treatment assignment adjusted for
baseline readiness to change as entered into the website
by the patient.
Discussion
Despite some success in targeting one aspect or another
of health services, single-dimension provider or patient
implementation strategies are inherently limited. Using
the Internet as a delivery method provides the potential
to link multiple provider and patient intervention com-
ponents, but this potential has not yet been realized.
Our goal is to link providers and patients through an
innovative electronic system with redundant cues and
reminders to encourage participation at all levels of the
clinical microsystem. Within the intervention group, the
system will provide the practices with feedback and the
patients with encouragement.
Once referred, the patient system has been developed
to include current innovations in online smoking cessa-
tion interventions. Standard components include educa-
tional materials, interactive decision support tools (e.g.,
“What do I have to overcome?”-an assessment of trig-
gers to smoking), and a quit plan tailored to readiness
to quit. Additional, more innovative components,
including online counseling with a tobacco treatment
specialist through an asynchronous secure messaging
system, are available in the augmented Decide2Quit.org.
Our goal is to analyze the impact of this integrated sys-
tem in terms of process (Refer and Go) and outcomes
(six-month smoking cessation).
Additional material
Additional File 1: Information prescription sheet for the
Intervention. A copy of the information prescription that will be
provided to the Intervention practices. This sheet contains a space for
the patient’s email, provider signature, and the smoking cessation
website address (Decide2Quit.org).
Additional File 2: Information prescription sheet for the practice-
level comparison arm. A copy of the information prescription that will
be provided to the Comparison practices. This sheet does not contain a
space for the patient’s email denoting the difference between the
intervention and comparison arm referral process.
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